5 completed, 3 unknown, 2 recruiting, 2 withdrawn. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 5, Unknown 3, Recruiting 2, Withdrawn 2, Not yet recruiting 1, Terminated 1 |
Follow Flecainide: new trials by email Literature Review of Flecainide trials Research Report on Flecainide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation flecainide, Sotalol or Amiodarone - Atrial Fibrillation (AF), Coronary Artery Disease | Phase 4 | Recruiting | Universitaire Ziekenhuizen KU Leuven | 988 | 2026-09-01 | 2026-10-21 |
| Dronedarone Rhythm Intervention for Early Atrial Fibrillation Dronedarone, flecainide, propafenone - Atrial Fibrillation (AF) | Phase 4 | Not yet recruiting | Inha University Hospital | 1898 | 2026-01-01 | 2025-12-22 |
| Single Dose Flecainide for Early Sinus Rhythm Conversion of Perioperative Atrial Fibrillation After Noncardiac Surgery Flecainide - Atrial Fibrillation, Surgery | Phase 4 | Withdrawn | Population Health Research Institute | 2024-07-01 | 2024-08-29 | |
| Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation Flecainide, Sotalol - Atrial Fibrillation | Phase 4 | Recruiting | University of Illinois at Chicago | 162 | 2020-12-31 | 2025-08-24 |
| Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract Carvedilol, Flecainide - Ventricular Premature Complexes, Outflow Tract | Phase 4 | Unknown | Keimyung University Dongsan Medical Center | 104 | 2017-09-05 | 2018-07-18 |
| Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents Vernakalant, Flecainide - Paroxysmal Atrial Fibrillation | Phase 4 | Completed | David Filgueiras-Rama | 50 | 2017-01-01 | 2023-08-07 |
| A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF single ablation (CryoBalloonAblation (CBA), sequential drug adjustment (propafenone, sotalol or flecainide) - Atrial Fibrillation | Phase 4 | Completed | University Hospital, Ghent | 13 | 2015-03-03 | 2023-08-01 |
| Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias antiarrhythmic drugs (Flecainide or Propafenone or Sotalol), Catheter Ablation - Ventricular Tachycardia, Ventricular Premature Complexes | Phase 4 | Unknown | Ospedale San Donato | 2013-01-01 | 2013-01-31 | |
| Vernakalant Versus Flecainide: Atrial Contractility Vernakalant, Flecainide - Atrial Fibrillation | Phase 4 | Unknown | Maastricht University Medical Center | 70 | 2012-08-01 | 2012-07-20 |
| Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation Antiarrhythmic drug, Catheter ablation - Atrial Fibrillation | Phase 4 | Withdrawn | Valley Health System | 2011-12-01 | 2014-12-16 | |
| Kansai Plus Atrial Fibrillation Trial ATP guide additional ablation., Antiarrhythmic drug (AAD), Control - Atrial Fibrillation | Phase 4 | Completed | Kyoto University, Graduate School of Medicine | 2113 | 2011-11-01 | 2017-08-18 |
| Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias flecainide, ajmaline, procainamide - Atrial Fibrillation, Tachycardia, Ventricular | Phase 4 | Completed | Hospital Clinic of Barcelona | 123 | 2008-06-01 | 2010-12-15 |
| A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation Radiofrequency ablation, antiarrhythmic drugs, Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs, ThermoCool Radiofrequency Catheter - Paroxysmal Atrial Fibrillation | Phase 4 | Completed | Biosense Webster, Inc. | 112 | 2003-08-01 | 2025-02-28 |
| Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation. Flecainide - Atrial Fibrillation | Phase 4 | Terminated | MEDA Pharma GmbH & Co. KG | 256 | 2022-02-07 |
Atrial Fibrillation (12) · Tachycardia, Ventricular (2) · Ventricular Premature Complexes (2) · Brugada Syndrome (1) · Coronary Artery Disease (1)
Biosense Webster, Inc. (1) · David Filgueiras-Rama (1) · Hospital Clinic of Barcelona (1) · Inha University Hospital (1) · Keimyung University Dongsan Medical Center (1) · Kyoto University, Graduate School of Medicine (1) · MEDA Pharma GmbH & Co. KG (1) · Maastricht University Medical Center (1) · Ospedale San Donato (1) · Population Health Research Institute (1) · Universitaire Ziekenhuizen KU Leuven (1) · University Hospital, Ghent (1) · University of Illinois at Chicago (1) · Valley Health System (1)
Belgium (3) · Spain (3) · United States (3) · France (2) · Netherlands (2) · South Korea (2) · Bulgaria (1) · Germany (1) · Italy (1) · Japan (1) · Romania (1) · Russia (1) · Switzerland (1)
Evegny Pokushalou, MD (1) · Harry Crijns, MD, PhD (1) · Jonathan Steinberg, MD (1) · Luc Jordaens, MD, PhD (1) · Pierre Jais, MD (1) · Prof E Aliot (1) · Satoshi Shizuta, MD (1) · Seongwook Han, M.D., Ph.D. (1) · Yong-Soo Baek, M.D., Ph.D. (1)
2025 (1)